Feedback / Questions
antolimab (AK002) - Allakos
http://www.globenewswire.com/news-release/2020/03/24/2005821/0/en/Allakos-Announces-Positive-Phase-1-Results-with-Antolimab-AK002-in-Mast-Cell-Gastrointestinal-Disease.html
Mar 24, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next